The Enterprise Value as of December 2025 (TTM) for Poniard Pharmaceuticals, Inc. (PARD) is 290.15K

According to Poniard Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 290.15K. This represents a change of -98.19% compared to the average of 16.02M of the last 4 quarters.

Poniard Pharmaceuticals, Inc. (PARD) Historical Enterprise Value (quarterly & annually)

How has PARD Enterprise Value performed in the past?

The mean historical Enterprise Value of Poniard Pharmaceuticals, Inc. over the last ten years is 16.84M. The current 290.15K Enterprise Value has changed 72.28% with respect to the historical average. Over the past ten years (40 quarters), PARD's Enterprise Value was at its highest in in the December 2009 quarter at 76.18M. The Enterprise Value was at its lowest in in the September 2006 quarter at -29525625.00.

Poniard Pharmaceuticals, Inc. (PARD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Poniard Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Poniard Pharmaceuticals, Inc. (PARD) Average Enterprise Value

How has PARD Enterprise Value performed in the past?

The current Enterprise Value of Poniard Pharmaceuticals, Inc. (PARD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Poniard Pharmaceuticals, Inc. (PARD) Enterprise Value vs. Peers

How is PARD’s Enterprise Value compared to its peers?

Poniard Pharmaceuticals, Inc.’s Enterprise Value is less than VioQuest Pharmaceuticals, Inc. (2.25M), less than Regenicin, Inc. (643.70K), less than Q BioMed Inc. (4.07M), greater than Scopus BioPharma Inc. (-104458.00), less than Strategic Partners A/S (35.45M), greater than RenovaCare, Inc. (-2809960.00), less than Vaxxinity, Inc. (10.87M), greater than PaxMedica, Inc. Common Stock (-4698079.00), less than NovAccess Global Inc. (2.18M), greater than Aeolus Pharmaceuticals, Inc. (-3139791.00),

Build a custom stock screener for Poniard Pharmaceuticals, Inc. (PARD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poniard Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Poniard Pharmaceuticals, Inc. (PARD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Poniard Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.